Mirsaeed Abdollahi

Dr. Mirsaeed Abdollahi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2025 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
Navid SobhiNavid Sobhi
Navid Sobhi
YSYasin Sadeghi-Bazargani
Yasin Sadeghi-Bazargani
MMMajid Mirzaei
Majid Mirzaei
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Background: Diabetes mellitus (DM) increases the risk of vascular complications, and retinal vasculature imaging serves as a valuable indicator of both microvascular and macrovascular health. Moreover, artificial intelligence (AI)-enabled systems developed for high-throughput detection of diabetic retinopathy (DR) using digitized retinal images have become clinically adopted. This study reviews AI applications using retinal images for DM-related complications, highlighting advancements beyond DR screening, diagnosis, and prognosis, and addresses implementation challenges, such as ethics, data privacy, equitable access, and explainability. Methods: We conducted a thorough literature search across several databases, including PubMed, Scopus, and Web of Science, focusing on studies involving diabetes, the retina, and artificial intelligence. We reviewed the original research based on their methodology, AI algorithms, data processing techniques, and validation procedures to ensure a detailed analysis of AI applications in diabetic retinal imaging. Results: Retinal images can be used to diagnose DM complications including DR, neuropathy, nephropathy, and atherosclerotic cardiovascular disease, as well as to predict the risk of cardiovascular events. Beyond DR screening, AI integration also offers significant potential to address the challenges in the comprehensive care of patients with DM. Conclusion: With the ability to evaluate the patient’s health status in relation to DM complications as well as risk prognostication of future cardiovascular complications, AI-assisted retinal image analysis has the potential to become a central tool for modern personalized medicine in patients with DM.
3

29 March 2025 in Artificial Intelligence Review
Verified
Journal Article
Open access
PDF file
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
SMShadi Farabi Maleki
Shadi Farabi Maleki
PPParnia Pouya
Parnia Pouya
Navid SobhiNavid Sobhi
Navid Sobhi
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Retinopathy of prematurity (ROP) is a severe condition affecting premature infants, leading to abnormal retinal blood vessel growth, retinal detachment, and potential blindness. While semi-automated systems have been used in the past to diagnose ROP-related plus disease by quantifying retinal vessel features, traditional machine learning (ML) models face challenges like accuracy and overfitting. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs), have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential. This research comprehensively examines the contemporary progress and challenges associated with using retinal imaging and artificial intelligence (AI) to detect ROP, offering valuable insights that can guide further investigation in this domain. Based on 84 original studies in this field (out of 2025 studies that were comprehensively reviewed), we concluded that traditional methods for ROP diagnosis suffer from subjectivity and manual analysis, leading to inconsistent clinical decisions. AI holds great promise for improving ROP management. This review explores AI’s potential in ROP detection, classification, diagnosis, and prognosis.
3

9 October 2024 in WIREs Data Mining and Knowledge Discovery
Verified
Journal Article
Open access
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
AGAmirhosein Ghafouri‐Asbagh
Amirhosein Ghafouri‐Asbagh
Navid SobhiNavid Sobhi
Navid Sobhi
KPKeysan Pourmoghtader
Keysan Pourmoghtader
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Cardiovascular diseases (CVDs) are the leading cause of death globally. The use of artificial intelligence (AI) methods—in particular, deep learning (DL)—has been on the rise lately for the analysis of different CVD‐related topics. The use of fundus images and optical coherence tomography angiography (OCTA) in the diagnosis of retinal diseases has also been extensively studied. To better understand heart function and anticipate changes based on microvascular characteristics and function, researchers are currently exploring the integration of AI with noninvasive retinal scanning. There is great potential to reduce the number of cardiovascular events and the financial strain on healthcare systems by utilizing AI‐assisted early detection and prediction of cardiovascular diseases on a large scale. A comprehensive search was conducted across various databases, including PubMed, Medline, Google Scholar, Scopus, Web of Sciences, IEEE Xplore, and ACM Digital Library, using specific keywords related to cardiovascular diseases and AI. The study included 87 English‐language publications selected for relevance, and additional references were considered. This article provides an overview of the recent developments and difficulties in using AI and retinal imaging to diagnose cardiovascular diseases. It provides insights for further exploration in this field. Researchers are trying to develop precise disease prognosis patterns in response to the aging population and the growing global burden of CVD. AI and DL are revolutionizing healthcare by potentially diagnosing multiple CVDs from a single retinal image. However, swifter adoption of these technologies in healthcare systems is required.This article is categorized under: Application Areas > Health Care Technologies > Artificial Intelligence
3

28 May 2024 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
Navid SobhiNavid Sobhi
Navid Sobhi
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
AAAli Arman
Ali Arman
AMAta Mahmoodpoor
Ata Mahmoodpoor
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
Methanol-induced optic neuropathy (MION) represents a critical public health issue, particularly prevalent in lower socioeconomic populations and regions with restricted alcohol access. MION, characterized by irreversible visual impairment, arises from the toxic metabolization of methanol into formaldehyde and formic acid, leading to mitochondrial oxidative phosphorylation inhibition, oxidative stress, and subsequent neurotoxicity. The pathogenesis involves axonal and glial cell degeneration within the optic nerve and potential retinal damage. Despite advancements in therapeutic interventions, a significant proportion of affected individuals endure persistent visual sequelae. The study comprehensively investigates the pathophysiology of MION, encompassing the absorption and metabolism of methanol, subsequent systemic effects, and ocular impacts. Histopathological changes, including alterations in retinal layers and proteins, Müller cell dysfunction, and visual symptoms, are meticulously examined to provide insights into the disease mechanism. Furthermore, preventive measures and public health perspectives are discussed to highlight the importance of awareness and intervention strategies. Therapeutic approaches, such as decontamination procedures, ethanol and fomepizole administration, hemodialysis, intravenous fluids, electrolyte balance management, nutritional therapy, corticosteroid therapy, and erythropoietin (EPO) treatment, are evaluated for their efficacy in managing MION. This comprehensive review underscores the need for increased awareness, improved diagnostic strategies, and more effective treatments to mitigate the impact of MION on global health.
3

18 January 2025 in Heliyon
Verified
Journal Article
Open access
Hadi VahediHadi Vahedi
Hadi Vahedi
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
RMReza Moshfeghinia
Reza Moshfeghinia
SEShima Emami
Shima Emami
Navid SobhiNavid Sobhi
Navid Sobhi
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
This systematic review and meta-analysis aimed to assess the changes in retinal layer thickness and vascular density in patients diagnosed with keratoconus (KC). We conducted a thorough search in PubMed, Scopus, Embase, and Web of Science, encompassing all observational studies from January 1990 to February 2024. We analyzed the data using STATA software 17 and the random effects model with the restricted maximum likelihood (REML) or maximum likelihood (ML) method to pool the standardized mean difference (SMD) and the weighted mean difference (WMD) of retinal thickness and vascular density compared to non-KC eyes. From 4608 records, 16 primary studies met our inclusion criteria, involving 1932 eyes in two groups. The meta-analysis revealed a significant reduction in retinal nerve fiber layer (RNFL) thickness (SMD: −0.30 [-0.52, −0.08]), perifoveal macular thickness in the nasal region (SMD: −0.32 [-0.55, −0.09]) and superior region (SMD: −0.24 [-0.47, −0.02]), and superior capillary plexus (SCP) density (SMD: −1.52 [-2.27, −0.77]) of KC eyes. Additionally, there was a mildly to moderately significant increase in the optic nerve head (ONH) disk area (SMD: 0.40 [0.06, 0.75]). However, there were no significant changes in foveal macular thickness, parafoveal macular thickness, or deep capillary plexus (DCP) density. In KC patients, significant alterations in retinal structure and vascular density have been observed. Although these changes do not currently influence treatment strategies, they offer valuable insights into the relationship between the retina and the cornea. Understanding these changes may be essential for future research focused on early detection, potential prognosis markers, and further exploration of the retina-corneal connection in KC.
3

3 January 2024 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MCMaryam Chenaghlou
Maryam Chenaghlou
FMFatemeh Abedi Mahzoon
Fatemeh Abedi Mahzoon
SHSina Hamzehzadeh
Sina Hamzehzadeh
ANAli Norouzi
Ali Norouzi
HSHadi Sahrai
Hadi Sahrai
EBErfan Banisefid
Erfan Banisefid
Background: Recent studies have shown that increases in serum UA levels are associated with adverse clinical outcomes in patients with chronic heart failure (CHF); the aim of this study was to determine the relationship between serum uric acid and total diuretic dose received during hospitalization in hospitalized patients with acute exacerbation of heart failure. The main purpose of this study is to determine the role of uric acid as a biomarker that can be a substitute for pro-BNP in clinical evaluation and the need for diuretics in hospitalized patients with acute heart failure. Methods: After approving the plan in the Research Council of the Heart Department and obtaining an ethical code from the Regional Committee on Research Ethics (Human Subjects Studies), the researcher referred to the archives of our center, the case of 100 patients diagnosed with acute heart failure. Cardiac patients were selected, and the information required for the study was collected using a pre-prepared data collection form, and the information was entered into SPSS software after categorization and appropriate analysis and statistical tests were performed on it. Were performed and in all statistical tests the statistical significance level was considered 0.05: Results: 100 patients with acute heart failure were included in this study with a mean age of 63.43 ± 14.78 years. 66% of them were men. The mean dose of furosemide in these patients was 680.92 ± 377.47 mg and the mean serum uric acid level in these patients was 8.55 ± 2.50 mg / dL. In the study of the relationship between the variables, there was a significant relationship between the dose of furosemide received with the serum level of serum uric acid (P = 0.017, r = 0.248 and P = 0.009, r = -0.267, respectively). There is also a significant relationship between serum uric acid level and patient mortality (P = 0.013, r = 0.247). However this relationship lost its significance after multivariate analysis. Conclusion: There is a significant relationship between serum uric acid level and diuretic use. However, in-hospital mortality is not related to uric acid levels at admission.